Susceptibility to cytomegalovirus infection may be dependent on the cytokine response to the virus

被引:17
作者
Geist, LJ
Hinde, SL
机构
[1] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[2] Dept Vet Affairs, Iowa City, IA USA
关键词
interleukin-10; viral infection; cytomegalovirus; genetic susceptibility;
D O I
10.2310/6650.2001.33788
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality in an immunocompromised host. Pulmonary infection with CMV results in an inflammatory response, which includes the local production of cytokines. Cytokine production stimulated by CMV infection serves to activate a series of immunologic responses involved in viral clearance. Previous work has demonstrated that different mouse strains express variable sensitivity to CW infection. Methods: Using mouse strains that express sensitive (BALB/cj) and resistant (C57BL/6) CMV phenotypes, we asked whether the differences in susceptibility to infection were caused by differences in pulmonary cytokine production after intraperitoneal infection with CMV. Results: C57 mice demonstrated a higher total bronchoalveolar lavage (BAL) and BAI, lymphocyte count at 3 and 7 days after intraperitoneal infection compared with BALB mice. There were no differences in BAI. cytokine production; however, we were able to demonstrate differences in CMV DNA load in the lungs of BALB mice compared with that of C57 mice. In addition, there appeared to be increased whole-lung production of the T(H)2 cytokine IL-10 in the BALB mice versus the C57 mice. Conclusions: This observation suggests that the genetic susceptibility to CMV infection may, in part, be regulated by differences in cytokines production within the local environment.
引用
收藏
页码:434 / 441
页数:8
相关论文
共 46 条
[21]   INTERLEUKIN-12 REGULATES THE PROLIFERATION OF TH1, BUT NOT TH2 OR TH0, CLONES [J].
KENNEDY, MK ;
PICHA, KS ;
SHANEBECK, KD ;
ANDERSON, DM ;
GRABSTEIN, KH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (10) :2271-2278
[22]   Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10) [J].
Kotenko, SV ;
Saccani, S ;
Izotova, LS ;
Mirochnitchenko, OV ;
Pestka, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (04) :1695-1700
[23]  
MACKINTOSH FR, 1993, EXP HEMATOL, V21, P243
[24]   INTERLEUKIN-10 [J].
MALEFYT, RD ;
YSSEL, H ;
RONCAROLO, MG ;
SPITS, H ;
DEVRIES, JE .
CURRENT OPINION IN IMMUNOLOGY, 1992, 4 (03) :314-320
[25]   INTERLEUKIN-10 CONTROLS INTERFERON-GAMMA AND TUMOR-NECROSIS-FACTOR PRODUCTION DURING EXPERIMENTAL ENDOTOXEMIA [J].
MARCHANT, A ;
BRUYNS, C ;
VANDENABEELE, P ;
DUCARME, M ;
GERARD, C ;
DELVAUX, A ;
DEGROOTE, D ;
ABRAMOWICZ, D ;
VELU, T ;
GOLDMAN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (05) :1167-1171
[26]   PATHOGENESIS OF ACUTE MURINE CYTOMEGALOVIRUS-INFECTION IN RESISTANT AND SUSCEPTIBLE STRAINS OF MICE [J].
MERCER, JA ;
SPECTOR, DH .
JOURNAL OF VIROLOGY, 1986, 57 (02) :497-504
[27]  
MILLER W, 1986, BLOOD, V67, P1162
[28]  
MULLIGAN MS, 1993, J IMMUNOL, V151, P5666
[29]   CELLULAR BASIS FOR SUSCEPTIBILITY TO MOUSE CYTOMEGALOVIRUS - EVIDENCE FROM TRACHEAL ORGAN-CULTURE [J].
NEDRUD, JG ;
COLLIER, AM ;
PAGANO, JS .
JOURNAL OF GENERAL VIROLOGY, 1979, 45 (DEC) :737-744
[30]   REQUIREMENT FOR NATURAL-KILLER CELL-PRODUCED INTERFERON-GAMMA IN DEFENSE AGAINST MURINE CYTOMEGALOVIRUS-INFECTION AND ENHANCEMENT OF THIS DEFENSE PATHWAY BY INTERLEUKIN-12 ADMINISTRATION [J].
ORANGE, JS ;
WANG, BP ;
TERHORST, C ;
BIRON, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (04) :1045-1056